SCISPARC LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.28 USD | +3.23% |
|
+1.59% | -73.77% |
| Apr. 11 | SciSparc Ltd. signed a merger agreement to acquire remaining stake in Automax Motors Ltd. | CI |
| Apr. 01 | SciSparc Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Financials (USD)
| Sales 2022 | 1.35 | Sales 2023 | 2.88 | Capitalization | 2.56M |
|---|---|---|---|---|---|
| Net income 2022 | -2M | Net income 2023 | -5M | EV / Sales 2022 | 1,145,812 x |
| Net cash position 2022 | 3.55M | Net cash position 2023 | 5M | EV / Sales 2023 | -848,893 x |
| P/E ratio 2022 |
-1.33
x | P/E ratio 2023 |
-0.34
x | Employees | 3 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.98% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +3.23% | ||
| 1 week | +1.59% | ||
| Current month | -8.57% | ||
| 1 month | -26.01% | ||
| 3 months | -63.94% | ||
| 6 months | -73.39% | ||
| Current year | -73.77% |
1 week
1.18
1.34
1 month
1.152.10
Current year
1.156.78
1 year
1.1523.66
3 years
0.00221.00
5 years
0.00221.00
10 years
0.00221.00
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-09 | 1.28 | +3.23% | 28 219 |
| 24-05-08 | 1.24 | +2.48% | 12,536 |
| 24-05-07 | 1.21 | -2.42% | 193,080 |
| 24-05-06 | 1.24 | -1.59% | 77,910 |
| 24-05-03 | 1.26 | 0.00% | 55,397 |
Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm EDT
More quotes
Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
Sector
Pharmaceuticals
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -73.77% | 3.35M | |
| +18.67% | 43.74B | |
| +21.99% | 22.26B | |
| +16.41% | 14.9B | |
| +9.03% | 13.39B | |
| +40.48% | 12.12B | |
| -9.64% | 6.92B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.41% | 5.47B |
- Stock Market
- Equities
- SPRC Stock